glp-1 vision loss ema recommendation november 2025 💊 Recent studies show that people taking drugs like Ozempic and Wegovy had up to 50% lower risk of compared to those on other medications. (More in our newsletter Wegovy Vision Loss Lawsuit [2026

Description

There are currently no controlled studies on microdosing GLP-1RAs, so everything at these doses remains anecdotal

GLP()

GLP-1 medications, widely known for their role in managing diabetes and obesity, present unique risks that could impact healthcare providers, including potential liability issues and regulatory challenges that can impact clients insurance needs

12:e17891

This narrative review aims to synthesize the existing evidence on the potential of GLP-1 RAs as a dual-action therapy for smoking cessation, with a particular focus on their ability to mitigate weight gain and improve overall outcomes